EMAIL THIS PAGE TO A FRIEND

The Journal of endocrinology

Glutamate dehydrogenase, insulin secretion, and type 2 diabetes: a new means to protect the pancreatic β-cell?


PMID 22232141

Abstract

In this issue of Journal of Endocrinology, Dr Han and colleagues report a protective effect of the glutamate dehydrogenase activator 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH) under diabetes-like conditions that impair β-cell function in both a pancreatic β-cell line and db/db mice. Based on these observations, the authors suggest that BCH could serve as a novel treatment modality in type 2 diabetes. The present commentary discusses the importance of the findings. Some additional questions are raised, which may be addressed in future investigations, as there is some concern regarding the BCH treatment of β-cell failure.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A7902
2-Amino-2-norbornanecarboxylic acid, amino acid transport inhibitor
C8H13NO2